Moneyline: PharMerica, FOSRx make buys

 - 
Wednesday, January 25, 2017

LOUISVILLE, Ky. – Amerita, the Specialty Infusion Division of PharMerica, has acquired Fairlawn, N.J.-based Nextron, a provider of certain specialty medications in the home. The move allows Amerita to further its expansion in the eastern United States.

“This expansion is consistent with our strategy to become a national home infusion provider,” said Greg Weishar, PharMerica's CEO, in a press release.

Paragon Ventures served as adviser to Nextron. Terms of the deal were not disclosed.

FOSRx closes deal

CUMBERLAND, Md. – Factor One Source Pharmacy has acquired Metairie, La.-based Fast Access Specialty Therapeutics. Together the two companies generated approximately $136 million dollars in revenue in 2016 and are projected to generate $156 million in revenue for 2017.

Sajal Roy, CEO of FOSRx, will become CEO of the combined companies.

FAST, which has 42 employees and annual revenue of nearly $100 million, will retain its brand but operate under the FOSRx umbrella.

Paragon Ventures served as adviser to Nextron. Terms of the deal were not disclosed.